Alnylam Pharmaceuticals | Stammkapital



Ordinary Share Capital Veränderung Datum
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Arrowhead Research USD 138.14M 137.91M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
PTC Therapeutics USD 79.38M 79.3M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Sanofi 1.25B 52.53M 2025-03
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Takeda JPY 1.56B 1.69T 2025-06
Tectonic Therapeutic USD 2K 0 2024-12
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06
Xencor USD 71.3M 70.58M 2025-06


Alnylam Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.